Navigation Links
Saebo United Kingdom Posts Record 2008; Sees Continued Growth in UK for 2009
Date:4/16/2009

National Health Service hospitals' usage by stroke rehab patients dictates increase in staff and Saebo-trained therapists

CHARLOTTE, N.C., April 16 /PRNewswire/ -- Saebo, Inc. announced in its first quarter that its subsidiary, Saebo UK, Ltd., had another record year in 2008 and has added staff to accommodate its continued impressive growth in 2009.

"2008 was another record year for Saebo UK," said UK Managing Director, Glyn Blakey. "In the second half of 2008 alone, we trained an additional 80 physiotherapists and occupational therapists, bringing the total to over 250 Saebo-trained therapists throughout the United Kingdom. Additional trainers, administrative staff and technical support personnel were hired to keep up with our growth to ensure we continue to provide excellent service and support to patients."

"We were also successful in selling the Saebo In-Patient Treatment

Programme in 2008 to a number of leading National Health Service (NHS) hospitals. These hospitals have embraced Saebo's products and we continue to have good success selling the In-Patient Treatment Kit to NHS facilities so far in 2009," Blakey concluded.

Henry Hoffman, President of Saebo, Inc. added, "Saebo UK was a big contributor to our overall success in 2008. The UK team has done a great job of building the business and the Saebo brand throughout the UK. The traction we are now gaining with the NHS, combined with the increase in the number of Saebo-trained therapists bodes well for another great year for Saebo UK."

About Saebo UK, Ltd.

Based 25 minutes north of London, Saebo UK, Ltd. is a wholly-owned subsidiary of Saebo, Inc. With a network of over 250 Saebo-trained therapists throughout the UK, Saebo UK provides products and services to hundreds of patients per year. For more information or to find a Saebo-trained therapist in the United Kingdom, go to www.saebo.com, go to the "International" page and click on the "United Kingdom" to look under "UK Locations."

About Saebo, Inc.

Saebo, Inc. is a global provider of innovative rehabilitation products for stroke survivors and other neurologically impaired individuals. Headquartered in Charlotte, NC, the company was founded in 2001 by two occupational therapists specializing in stroke rehabilitation. Saebo's pioneering treatment protocols are based on new research documenting the brain's remarkable ability to "re-program" itself following injury. The company's neurological orthotic devices, SaeboFlex and SaeboReach, allow patients with very little residual hand function to forge new pathways in the brain to immediately begin grasping and releasing objects in high repetition exercises. Named Most Valuable Product in 2008 by Therapy Times, the SaeboFlex and SaeboReach are now offered at over 1,500 clinics and hospitals nationwide. Used within 22 of the "Top 25 Rehabilitation Hospitals" (U.S. News & World Report), Saebo products are eligible for reimbursement by Medicare and most commercial insurers. A network of over 3,400 trained clinicians, spanning four continents, is committed to helping stroke survivors around the globe achieve a new level of independence. www.saebo.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Henry Hoffman

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87812


'/>"/>
SOURCE Saebo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Saebo Expands Internet Presence With Launch of New Website
2. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
3. United States continues to have highest level of health spending
4. United Medicorp, Inc.s Shareholders Approve All Proposals
5. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
6. Medical Services International Received Its First Order for Testing By Regulatory Agencies in the United States
7. Peoples United Financial CEO Has Surgery
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. More Than 100 Organizations Call for a National AIDS Strategy to End the Epidemic in the United States
10. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
11. Universal Health Care Coverage in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: